This book is the most comprehensive and complete treatise on nucleic
acid therapeutic products, including mRNA vaccines, their
manufacturing, formulations, and testing for safety and efficacy.
Details include cGMP-compliant manufacturing and regulatory filing
steps. A new concept of “biosimilar” mRNA vaccine is presented to
secure fast approval of copies of mRNA vaccines. Projections of
financial plans to establish RNA manufacturing facilities are
provided, along with details of supply chain management. Finally, the
future of nucleic acid products in gene therapy and other newer
applications is presented, along with a perspective that all new
vaccines will be the nucleic acid type that will further provide
first-time prevention of autoimmune disorders. It is projected that
both big pharma and start-ups will enter this field, and we can expect
significant additions to our drug armamentarium soon.
Les mer
Fast-to-Market Strategies
Produktdetaljer
ISBN
9781000788112
Publisert
2022
Utgave
1. utgave
Utgiver
Vendor
CRC Press
Språk
Product language
Engelsk
Format
Product format
Digital bok
Forfatter